Numis announced Allergy Therapeutics PLC (LON:AGY), upholding its stock price target at 37.00GBX today
- Updated: September 25, 2016
In a report released on 09/26/2016 Numis hold steady the stock price target of Allergy Therapeutics PLC (LON:AGY) from 37.00GBX to 37.00GBX reporting a possible upside of 1.10%.
Previously on Wednesday September 21, 2016, Numis released a statement about Allergy Therapeutics PLC (LON:AGY) increased the target price from 0.00GBX to 37.00GBX. At the time, this indicated a possible upside of 1.01%.
Just yesterday Allergy Therapeutics PLC (LON:AGY) traded -2.86% lower at 17.63GBX. Allergy Therapeutics PLC’s 50-day moving average is 18.77GBX and its 200-day moving average is 22.69GBX. The last stock price is down -21.34% from the 200-day moving average, compared to the Standard & Poor's 500 Index which has decreased -0.01% over the same time period. 214,033 shares of AGY traded hands, down from an average trading volume of 256,727
Recent Performance Chart
Allergy Therapeutics PLC has with a one year low of 17.29GBX and a one year high of 34.82GBX and has a market capitalization of 0 GBX.
A total of 3 analysts have released a report on Allergy Therapeutics PLC. One analyst rating the company a strong buy, one analyst rating the company a buy, zero analysts rating the company a hold, zero analysts rating the company a underperform, and finally zero analysts rating the company a sell with a 12-month price target of 64.67GBX.
General Company Details For Allergy Therapeutics PLC (LON:AGY)
Allergy Therapeutics Plc is a United Kingdom-based pharmaceutical company. The Company focuses on the treatment and prevention of allergy with aluminum free products. It provides information to healthcare professionals about the prevention, diagnosis and treatment of allergic conditions with focus on allergy vaccination, which is also known as specific immunotherapy or desensitization therapy. The Company's business segments are Central Europe, which includes segments, such as Germany, Austria, Switzerland and the Netherlands; Southern Europe, which includes segments, such as Italy and Spain; the United Kingdom, which includes Latin America, and Rest of World. It offers products, such as Pollinex Trees, Pollinex Grasses + Rye and Skin Prick Testing; Diagnostic Products, such as Pollen, Foods, Moulds, Arthropods and Epithelia, and the United Kingdom Special products, including Pollinex Quattro, Tyrosine TU t.o.p, Oralvac Compact, and DAP Penicillin/DAP Amoxicillin/DAP Clavulanic.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.